RenovoRx (RNXT) announced that the Northwell Health Cancer Institute, NHCI, in New Hyde Park, NY is enrolling patients with locally advanced pancreatic cancer, LAPC, in the Company’s ongoing pivotal Phase III TIGeR-PaC clinical trial. NHCI joins clinical sites throughout the United States participating in the study.
Maximize Your Portfolio with Data Driven Insights:
- Leverage the power of TipRanks' Smart Score, a data-driven tool to help you uncover top performing stocks and make informed investment decisions.
- Monitor your stock picks and compare them to top Wall Street Analysts' recommendations with Your Smart Portfolio